Oncology Biomarker and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Oncology Biomarker Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Biomarker Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Biomarker Overall Market Size
2.1 Global Oncology Biomarker Market Size: 2022 VS 2030
2.2 Global Oncology Biomarker Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncology Biomarker Players in Global Market
3.2 Top Global Oncology Biomarker Companies Ranked by Revenue
3.3 Global Oncology Biomarker Revenue by Companies
3.4 Top 3 and Top 5 Oncology Biomarker Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oncology Biomarker Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Biomarker Players in Global Market
3.6.1 List of Global Tier 1 Oncology Biomarker Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncology Biomarker Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncology Biomarker Market Size Markets, 2022 & 2030
4.1.2 Lung Cancer
4.1.3 Breast Cancer
4.1.4 Colorectal Cancer
4.1.5 Prostate Cancer
4.1.6 Stomach Cancer
4.1.7 Others
4.2 By Type - Global Oncology Biomarker Revenue & Forecasts
4.2.1 By Type - Global Oncology Biomarker Revenue, 2018-2023
4.2.2 By Type - Global Oncology Biomarker Revenue, 2024-2030
4.2.3 By Type - Global Oncology Biomarker Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncology Biomarker Market Size, 2022 & 2030
5.1.2 Diagnostics
5.1.3 Drug Discovery And Development
5.1.4 Prognostics
5.1.5 Risk Assessment
5.1.6 Others
5.2 By Application - Global Oncology Biomarker Revenue & Forecasts
5.2.1 By Application - Global Oncology Biomarker Revenue, 2018-2023
5.2.2 By Application - Global Oncology Biomarker Revenue, 2024-2030
5.2.3 By Application - Global Oncology Biomarker Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Oncology Biomarker Market Size, 2022 & 2030
6.2 By Region - Global Oncology Biomarker Revenue & Forecasts
6.2.1 By Region - Global Oncology Biomarker Revenue, 2018-2023
6.2.2 By Region - Global Oncology Biomarker Revenue, 2024-2030
6.2.3 By Region - Global Oncology Biomarker Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Oncology Biomarker Revenue, 2018-2030
6.3.2 US Oncology Biomarker Market Size, 2018-2030
6.3.3 Canada Oncology Biomarker Market Size, 2018-2030
6.3.4 Mexico Oncology Biomarker Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Oncology Biomarker Revenue, 2018-2030
6.4.2 Germany Oncology Biomarker Market Size, 2018-2030
6.4.3 France Oncology Biomarker Market Size, 2018-2030
6.4.4 U.K. Oncology Biomarker Market Size, 2018-2030
6.4.5 Italy Oncology Biomarker Market Size, 2018-2030
6.4.6 Russia Oncology Biomarker Market Size, 2018-2030
6.4.7 Nordic Countries Oncology Biomarker Market Size, 2018-2030
6.4.8 Benelux Oncology Biomarker Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Oncology Biomarker Revenue, 2018-2030
6.5.2 China Oncology Biomarker Market Size, 2018-2030
6.5.3 Japan Oncology Biomarker Market Size, 2018-2030
6.5.4 South Korea Oncology Biomarker Market Size, 2018-2030
6.5.5 Southeast Asia Oncology Biomarker Market Size, 2018-2030
6.5.6 India Oncology Biomarker Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Oncology Biomarker Revenue, 2018-2030
6.6.2 Brazil Oncology Biomarker Market Size, 2018-2030
6.6.3 Argentina Oncology Biomarker Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncology Biomarker Revenue, 2018-2030
6.7.2 Turkey Oncology Biomarker Market Size, 2018-2030
6.7.3 Israel Oncology Biomarker Market Size, 2018-2030
6.7.4 Saudi Arabia Oncology Biomarker Market Size, 2018-2030
6.7.5 UAE Oncology Biomarker Market Size, 2018-2030
7 Oncology Biomarker Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Oncology Biomarker Major Product Offerings
7.1.4 Abbott Laboratories Oncology Biomarker Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Company Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Oncology Biomarker Major Product Offerings
7.2.4 Bristol-Myers Squibb Oncology Biomarker Revenue in Global Market (2018-2023)
7.2.5 Bristol-Myers Squibb Key News & Latest Developments
7.3 Eli Lilly and Company
7.3.1 Eli Lilly and Company Company Summary
7.3.2 Eli Lilly and Company Business Overview
7.3.3 Eli Lilly and Company Oncology Biomarker Major Product Offerings
7.3.4 Eli Lilly and Company Oncology Biomarker Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly and Company Key News & Latest Developments
7.4 F.Hoffmann-La Roche Ltd.
7.4.1 F.Hoffmann-La Roche Ltd. Company Summary
7.4.2 F.Hoffmann-La Roche Ltd. Business Overview
7.4.3 F.Hoffmann-La Roche Ltd. Oncology Biomarker Major Product Offerings
7.4.4 F.Hoffmann-La Roche Ltd. Oncology Biomarker Revenue in Global Market (2018-2023)
7.4.5 F.Hoffmann-La Roche Ltd. Key News & Latest Developments
7.5 Genomic Health
7.5.1 Genomic Health Company Summary
7.5.2 Genomic Health Business Overview
7.5.3 Genomic Health Oncology Biomarker Major Product Offerings
7.5.4 Genomic Health Oncology Biomarker Revenue in Global Market (2018-2023)
7.5.5 Genomic Health Key News & Latest Developments
7.6 GlaxoSmithKline plc
7.6.1 GlaxoSmithKline plc Company Summary
7.6.2 GlaxoSmithKline plc Business Overview
7.6.3 GlaxoSmithKline plc Oncology Biomarker Major Product Offerings
7.6.4 GlaxoSmithKline plc Oncology Biomarker Revenue in Global Market (2018-2023)
7.6.5 GlaxoSmithKline plc Key News & Latest Developments
7.7 Novartis AG
7.7.1 Novartis AG Company Summary
7.7.2 Novartis AG Business Overview
7.7.3 Novartis AG Oncology Biomarker Major Product Offerings
7.7.4 Novartis AG Oncology Biomarker Revenue in Global Market (2018-2023)
7.7.5 Novartis AG Key News & Latest Developments
7.8 Merck & Co.
7.8.1 Merck & Co. Company Summary
7.8.2 Merck & Co. Business Overview
7.8.3 Merck & Co. Oncology Biomarker Major Product Offerings
7.8.4 Merck & Co. Oncology Biomarker Revenue in Global Market (2018-2023)
7.8.5 Merck & Co. Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Oncology Biomarker Major Product Offerings
7.9.4 Pfizer Oncology Biomarker Revenue in Global Market (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
7.10 Qiagen N.V.
7.10.1 Qiagen N.V. Company Summary
7.10.2 Qiagen N.V. Business Overview
7.10.3 Qiagen N.V. Oncology Biomarker Major Product Offerings
7.10.4 Qiagen N.V. Oncology Biomarker Revenue in Global Market (2018-2023)
7.10.5 Qiagen N.V. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Oncology Biomarker Market Opportunities & Trends in Global Market
Table 2. Oncology Biomarker Market Drivers in Global Market
Table 3. Oncology Biomarker Market Restraints in Global Market
Table 4. Key Players of Oncology Biomarker in Global Market
Table 5. Top Oncology Biomarker Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Oncology Biomarker Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Oncology Biomarker Revenue Share by Companies, 2018-2023
Table 8. Global Companies Oncology Biomarker Product Type
Table 9. List of Global Tier 1 Oncology Biomarker Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology Biomarker Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Oncology Biomarker Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Oncology Biomarker Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Oncology Biomarker Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Oncology Biomarker Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Oncology Biomarker Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Oncology Biomarker Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Oncology Biomarker Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Oncology Biomarker Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Oncology Biomarker Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Oncology Biomarker Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Oncology Biomarker Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Oncology Biomarker Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Oncology Biomarker Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Oncology Biomarker Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Oncology Biomarker Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Oncology Biomarker Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Oncology Biomarker Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Oncology Biomarker Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Oncology Biomarker Revenue, (US$, Mn), 2024-2030
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Oncology Biomarker Product Offerings
Table 32. Abbott Laboratories Oncology Biomarker Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Bristol-Myers Squibb Company Summary
Table 35. Bristol-Myers Squibb Oncology Biomarker Product Offerings
Table 36. Bristol-Myers Squibb Oncology Biomarker Revenue (US$, Mn) & (2018-2023)
Table 37. Bristol-Myers Squibb Key News & Latest Developments
Table 38. Eli Lilly and Company Company Summary
Table 39. Eli Lilly and Company Oncology Biomarker Product Offerings
Table 40. Eli Lilly and Company Oncology Biomarker Revenue (US$, Mn) & (2018-2023)
Table 41. Eli Lilly and Company Key News & Latest Developments
Table 42. F.Hoffmann-La Roche Ltd. Company Summary
Table 43. F.Hoffmann-La Roche Ltd. Oncology Biomarker Product Offerings
Table 44. F.Hoffmann-La Roche Ltd. Oncology Biomarker Revenue (US$, Mn) & (2018-2023)
Table 45. F.Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 46. Genomic Health Company Summary
Table 47. Genomic Health Oncology Biomarker Product Offerings
Table 48. Genomic Health Oncology Biomarker Revenue (US$, Mn) & (2018-2023)
Table 49. Genomic Health Key News & Latest Developments
Table 50. GlaxoSmithKline plc Company Summary
Table 51. GlaxoSmithKline plc Oncology Biomarker Product Offerings
Table 52. GlaxoSmithKline plc Oncology Biomarker Revenue (US$, Mn) & (2018-2023)
Table 53. GlaxoSmithKline plc Key News & Latest Developments
Table 54. Novartis AG Company Summary
Table 55. Novartis AG Oncology Biomarker Product Offerings
Table 56. Novartis AG Oncology Biomarker Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis AG Key News & Latest Developments
Table 58. Merck & Co. Company Summary
Table 59. Merck & Co. Oncology Biomarker Product Offerings
Table 60. Merck & Co. Oncology Biomarker Revenue (US$, Mn) & (2018-2023)
Table 61. Merck & Co. Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Oncology Biomarker Product Offerings
Table 64. Pfizer Oncology Biomarker Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Key News & Latest Developments
Table 66. Qiagen N.V. Company Summary
Table 67. Qiagen N.V. Oncology Biomarker Product Offerings
Table 68. Qiagen N.V. Oncology Biomarker Revenue (US$, Mn) & (2018-2023)
Table 69. Qiagen N.V. Key News & Latest Developments
List of Figures
Figure 1. Oncology Biomarker Segment by Type in 2022
Figure 2. Oncology Biomarker Segment by Application in 2022
Figure 3. Global Oncology Biomarker Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oncology Biomarker Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Oncology Biomarker Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncology Biomarker Revenue in 2022
Figure 8. By Type - Global Oncology Biomarker Revenue Market Share, 2018-2030
Figure 9. By Application - Global Oncology Biomarker Revenue Market Share, 2018-2030
Figure 10. By Type - Global Oncology Biomarker Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Oncology Biomarker Revenue Market Share, 2018-2030
Figure 12. By Application - Global Oncology Biomarker Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Oncology Biomarker Revenue Market Share, 2018-2030
Figure 14. By Region - Global Oncology Biomarker Revenue Market Share, 2018-2030
Figure 15. By Country - North America Oncology Biomarker Revenue Market Share, 2018-2030
Figure 16. US Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Oncology Biomarker Revenue Market Share, 2018-2030
Figure 20. Germany Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 21. France Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Oncology Biomarker Revenue Market Share, 2018-2030
Figure 28. China Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 32. India Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Oncology Biomarker Revenue Market Share, 2018-2030
Figure 34. Brazil Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Oncology Biomarker Revenue Market Share, 2018-2030
Figure 37. Turkey Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Oncology Biomarker Revenue, (US$, Mn), 2018-2030
Figure 41. Abbott Laboratories Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bristol-Myers Squibb Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Eli Lilly and Company Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. F.Hoffmann-La Roche Ltd. Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Genomic Health Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. GlaxoSmithKline plc Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis AG Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Merck & Co. Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Qiagen N.V. Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
